Home > Healthcare > Biotechnology > Biotechnology R&D > Gene Synthesis Market

Gene Synthesis Market Trends

Report ID: GMI5636
Published Date: May 2023
Report Format: PDF

Download Free Sample

Gene Synthesis Market Trends

Various regional and national government research agencies around the globe are recognizing the potential of gene synthesis to drive innovation and economic growth. Increasing government investment for research and development in advancing technologies such as gene synthesis and CRISPR gene editing is estimated to proliferate the market development.

For instance, according to Association of American Medical Colleges, in 2021, the U.S. government invested USD 1.7 billion in genome sequencing to improve the detection, monitoring, and mitigation of SARS-CoV-2 variants. Also, various market players are raising funds to advance enzymatic DNA synthesis technology. Similarly in 2021, Molecular Assemblies received USD 25.8 million funding from Casdin Capital to enhance enzymatic DNA synthesis technology.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for gene synthesis was USD 2.1 billion in 2022 and will observe a 18.7% CAGR between 2023 and 2032.

Academic and research institutes segment will be over USD 6.5 billion in 2032 owing to the numerous advantages of these services.

North America gene synthesis market share was over 38% in 2022 and will grow by 2032 due to factors like growing R&D investments and CROs providing gene synthesis services.

Thermo Fisher Scientific, Inc., Eurofins Genomics, Brooks Automation, Inc (GENEWIZ), GenScript among others are the major players operating in the gene synthesis industry.